The intervention had beneficial therapeutic effects in PFD rats, where poly lactic-co- glycolic acid nanoparticles were first loaded, followed by loading of basic fibroblast growth factor to enable continuous release of the former, which enhanced the therapeutic effects of BMSCs with modified elastin gene. The gene discussed is ELN; the disease is polyostotic fibrous dysplasia.